-->
0
Trades des membres
) | |||||||||||||
20/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 4.38 | 6.20 | 41.31% | 124 | ||||||
08/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 4.33 | 6.20 | 42.94% | 129 | ||||||
31/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.33 | 12.42 | 272.50% | 818 | ||||||
31/01/20 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.89 | 3.40 | -12.78% | -38 | ||||||
12/11/19 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.80 | 3.40 | -10.72% | -32 | ||||||
08/11/19 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.68 | 3.40 | -7.80% | -23 | ||||||
14/10/19 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.78 | 3.75 | -0.99% | -3 | ||||||
27/03/19 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 4.06 | 3.75 | -7.83% | -23 | ||||||
11/03/19 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 4.04 | 3.75 | -7.37% | -22 | ||||||
12/02/19 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.87 | 3.51 | -9.49% | -19 | ||||||
11/02/19 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.85 | 3.35 | -13.17% | -26 | ||||||
11/02/19 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.76 | 7.52 | 99.70% | 199 | ||||||
16/11/18 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.23 | 3.45 | 6.60% | 13 | ||||||
14/11/18 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.22 | 3.78 | 17.17% | 34 | ||||||
31/10/18 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.50 | 3.80 | 8.36% | 25 | ||||||
12/04/18 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 4.37 | 3.78 | -13.69% | -41 | ||||||
06/04/18 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 4.51 | 3.45 | -23.68% | -142 | ||||||
27/02/18 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.71 | 4.84 | 30.23% | 181 | ||||||
12/02/18 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 3.60 | 4.14 | 14.79% | 89 | ||||||
08/01/18 | OSE IMMUNOTHERAPEUTICS | Achat | Sergio77n2 (390) | 4.14 | 3.95 | -4.78% | -29 | ||||||
Enregistrements 21 à 40 sur 40 | |||||||||||||